반응식
[C:1]([O:18][CH:19]([CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39][CH2:40][CH2:41][CH2:42][CH2:43][CH2:44][CH3:45])[CH2:20][C:21]([NH:23][C@H:24]([C:28]([OH:30])=O)[CH:25]([CH3:27])[CH3:26])=[O:22])(=[O:17])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16].[NH2:46][CH2:47][CH2:48][S:49]([OH:52])(=[O:51])=[O:50]>>[C:1]([O:18][CH:19]([CH2:31][CH2:32][CH2:33][CH2:34][CH2:35][CH2:36][CH2:37][CH2:38][CH2:39][CH2:40][CH2:41][CH2:42][CH2:43][CH2:44][CH3:45])[CH2:20][C:21]([NH:23][C@H:24]([C:28]([NH:46][CH2:47][CH2:48][S:49]([OH:52])(=[O:51])=[O:50])=[O:30])[CH:25]([CH3:26])[CH3:27])=[O:22])(=[O:17])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH2:10][CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16]참가 물질
3
실험 절차
Starting from N-(3-hexadecanoyloxyoctadecanoyl)-L-valine (1.28 g) and taurine (1 g), N-[N-(3-hexadecanoyloxyoctadecanoyl)-L-valyl]taurine (400 mg) was obtained as powder according to a similar manner to that of Example 32.
출처 및 근거
- ORD 기록
- ord-69bb110d995f4bb4ad248d28a1ecef27
- 출처 데이터셋
- uspto-grants-1987_02
- 특허 번호
- US04643990
연결된 노트
불러오는 중…